Market revenue in 2020 | USD 103.4 million |
Market revenue in 2028 | USD 291.0 million |
Growth rate | 13.8% (CAGR from 2020 to 2028) |
Largest segment | Lymphoma |
Fastest growing segment | Lymphoma |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Leukemia, Lymphoma, MPNs, Other Cancers |
Key market players worldwide | Roche Holding AG, Abbott Laboratories, Qiagen NV, Danaher Corp, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Illumina Inc, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemato oncology testing market will help companies and investors design strategic landscapes.
Lymphoma was the largest segment with a revenue share of 45.94% in 2020. Horizon Databook has segmented the France hemato oncology testing market based on leukemia, lymphoma, mpns, other cancers covering the revenue growth of each sub-segment from 2018 to 2028.
France is expected to exhibit lucrative growth during the forecast period owing to high incidence of blood cancers, local presence of major market players, and growing awareness about early diagnosis & treatment of blood cancer.
According to data published by Globocan in 2020, around 11,720 new cases of leukemia, 14,446 new cases of non-Hodgkin lymphoma were diagnosed in France. According to same source, around 6,907, 5 859, and 257 patients died due to leukemia, non-Hodgkin lymphoma, and Hodgkin lymphoma, respectively, in France.
Such high incidence and mortality rate has driven the demand for advance testing solutions and supported the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the France hemato oncology testing market , including forecasts for subscribers. This country databook contains high-level insights into France hemato oncology testing market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account